7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 
      
    		                 
      cash flows from operating activities
    		                 
      net income
    		-38,846,000 -42,684,000 -52,195,000 -191,935,000 -44,583,000 -45,809,000 -60,667,000 -52,930,000 -50,853,000 -63,890,000 -66,959,000 -8,397,000 -70,254,000 -36,323,000 -68,144,000 -83,706,000 -48,875,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                 
      stock-based compensation expense
    		5,232,000 5,004,000 6,024,000 8,083,000 7,622,000 8,284,000 9,155,000 8,463,000 10,516,000 14,223,000 13,882,000 18,363,000 19,123,000 22,410,000 22,028,000 21,178,000 13,042,000 
      depreciation and amortization expense
    		2,566,000 3,135,000 3,441,000 5,026,000 4,680,000 4,901,000 5,024,000 5,057,000 5,104,000 5,062,000 5,027,000 5,041,000 4,621,000     
      loss on securities purchase agreement put/call
    		                 
      net amortization and accretion on marketable securities
    		-1,009,000 -1,165,000 -1,725,000 -2,965,000 -3,587,000 -3,762,000 -4,367,000 -3,384,000 -2,287,000 -2,075,000 -1,850,000 -1,208,000 -428,000     
      loss on property and equipment disposals
    		-249,000 2,468,000 1,291,000 924,000 402,000 0 15,000 437,000 642,000    13,000     
      non-cash lease income
    		-995,000 -806,000 -710,000 -607,000 -612,000 -606,000 -373,000 -529,000 -528,000 -523,000 -293,000   -441,000 -214,000   
      change in fair value of contingent consideration payable
    		369,000 -864,000 -1,211,000               
      impairment of long-lived assets
    		0                 
      change in fair value of success payment liabilities
    		461,000 -115,000 -125,000 -496,000 -103,000 -1,534,000 968,000 529,000 -2,706,000 1,105,000 -1,708,000 -7,307,000 2,441,000 3,587,000 -3,851,000 -15,630,000 110,000 
      gain on marketable equity security
    		1,000 2,000 26,000 17,000 102,000             
      impairment of other investments
    		   0 0 0 13,001,000 0 0 2,923,000 10,000,000 0      
      changes in operating assets and liabilities:
    		                 
      prepaid expenses, other current assets and other assets
    		420,000 2,796,000 2,000,000 3,636,000 -1,615,000 -841,000 595,000 3,148,000 -664,000 1,049,000 -408,000 -1,296,000 -681,000 406,000 -397,000   
      accounts payable
    		-779,000 -231,000 -1,654,000 -2,036,000 -568,000 -517,000 -113,000 425,000 -1,410,000 380,000 2,069,000 -526,000 23,000 -1,767,000 2,937,000 99,000 -988,000 
      accrued liabilities and other current liabilities
    		572,000 -3,330,000 -9,788,000 -1,254,000 3,094,000 516,000 -3,606,000 -1,739,000 4,612,000 2,268,000 -5,860,000 5,373,000 1,323,000 -766,000 -6,393,000 -6,250,000  
      other non-current liabilities
    		-349,000 -111,000 -112,000 -312,000 126,000 -112,000 -113,000 -112,000 -112,000 -113,000 -112,000 -114,000 -113,000 -113,000 -113,000 -446,000  
      net cash from operating activities
    		-28,577,000 -34,458,000 -54,738,000 -47,242,000 -35,042,000 -38,094,000 -42,016,000 -40,635,000 -37,686,000 -39,161,000 -46,212,000 -40,267,000 -37,103,000 -44,333,000 -47,852,000 -33,173,000 -25,532,000 
      capex
    		-62,000 -314,000 -91,000 77,000 -86,000 -501,000 190,000 2,000 -226,000 -1,295,000 -1,138,000 -6,820,000 -2,781,000 -3,724,000 -9,626,000 -11,095,000 -12,746,000 
      free cash flows
    		-28,639,000 -34,772,000 -54,829,000 -47,165,000 -35,128,000 -38,595,000 -41,826,000 -40,633,000 -37,912,000 -40,456,000 -47,350,000 -47,087,000 -39,884,000 -48,057,000 -57,478,000 -44,268,000 -38,278,000 
      cash flows from investing activities
    		                 
      purchases of property and equipment
    		-62,000 -168,000 -246,000 -44,000 -59,000 -331,000 -30,000 -25,000 -195,000 -933,000 -1,533,000 -4,582,000 -2,791,000 -7,170,000 -9,733,000 -10,268,000 -11,599,000 
      sales of property and equipment
    		                0 
      purchases of marketable securities
    		-70,987,000 -80,701,000 -84,411,000 -38,802,000 -131,430,000 -116,464,000 -108,011,000 -256,785,000 -78,280,000 -33,255,000 -108,560,000 -59,669,000 -160,792,000 -89,659,000 -96,196,000 -133,924,000 -275,311,000 
      maturities of marketable securities
    		74,135,000 93,516,000 154,123,000 123,697,000 133,407,000 161,802,000 130,035,000           
      net cash from investing activities
    		3,349,000 12,647,000 69,466,000 53,505,000 1,918,000 45,007,000 21,994,000 -100,690,000 99,672,000 152,912,000 32,154,000 46,648,000 -57,085,000 25,019,000 -26,122,000 -73,902,000 -144,874,000 
      cash flows from financing activities
    		                 
      proceeds from securities purchase agreement equity issuance
    		                 
      proceeds from exercise of stock options
    		   -1,000 0 52,000 103,000 151,000 72,000   325,000 5,127,000 1,570,000 2,555,000 7,399,000 529,000 
      proceeds from employee stock purchase plan
    		0   438,000 0   731,000 0   632,000 0     
      taxes paid related to net share settlement of equity awards
    		  1,000 0 0 0 -76,000 -123,000 -215,000 -50,000 -69,000 -94,000      
      net cash from financing activities
    		50,000,000 183,000 1,000 437,000 0 862,000 27,000 759,000 -143,000 1,196,000 -69,000 863,000 4,760,000 2,457,000 2,555,000 7,399,000 -531,000 
      net increase in cash, cash equivalents and restricted cash
    		  14,729,000 6,700,000 -33,124,000   -140,566,000 61,843,000   7,244,000 -89,428,000 -16,857,000 -71,419,000 -99,676,000 -170,937,000 
      cash, cash equivalents and restricted cash at beginning of period
    		0 0 107,287,000 0 0 0 145,931,000 0 0 0 123,834,000 0 0 0 294,294,000 0 0 
      cash, cash equivalents and restricted cash at end of period
    		24,772,000 -21,628,000 122,016,000 6,700,000 -33,124,000 7,775,000 125,936,000 -140,566,000 61,843,000 114,947,000 109,707,000 7,244,000 -89,428,000 -16,857,000 222,875,000 -99,676,000 -170,937,000 
      represented by:
    		                 
      cash and cash equivalents
    		24,771,000 -21,524,000 120,328,000 5,298,000 -33,125,000 7,774,000 125,650,000 -140,567,000 61,842,000 114,946,000 109,426,000 7,243,000 -89,428,000 -16,857,000 222,596,000 -99,676,000 -170,937,000 
      restricted cash
    		1,000 -104,000 1,688,000 1,402,000 1,000 1,000 286,000 1,000 1,000 1,000 281,000 1,000 0 0 279,000 0 0 
      total
    		24,772,000 -21,628,000 122,016,000 6,700,000 -33,124,000 7,775,000 125,936,000 -140,566,000 61,843,000 114,947,000 109,707,000 7,244,000 -89,428,000 -16,857,000 222,875,000 -99,676,000 -170,937,000 
      supplemental cash flow information
    		                 
      cash paid for amounts included in the measurement of lease liabilities
    		3,167,000 3,157,000 3,095,000 3,018,000 2,898,000 2,892,000 2,659,000 2,815,000 2,815,000 2,809,000 2,406,000 2,734,000 2,737,000 2,727,000 2,672,000 2,888,000 2,759,000 
      non-cash investing and financing activities:
    		                 
      securities purchase agreement put/call issuance
    		                 
      equity issued for contingent consideration — immpact bio usa inc. acquisition
    		                 
      purchases of property and equipment included in accounts payable and accrued liabilities
    		 -146,000 155,000 121,000 -27,000 -170,000 220,000 27,000 -31,000 -362,000 395,000 -2,238,000 10,000 3,446,000 107,000 -827,000 -1,147,000 
      net decrease in cash, cash equivalents and restricted cash
    		      -19,995,000    -14,127,000       
      acquired ipr&d expense
    		                 
      change in fair value of equity warrant
    		           0      
      gain on other investments
    		                 
      deferred revenue
    		           -48,354,000 1,000 -35,742,000 -558,000 -2,811,000 -2,640,000 
      operating lease liabilities, non-current
    		           1,524,000 1,196,000 0 2,135,000   
      acquisition of assets, net of cash acquired
    		                 
      cash received for amounts related to tenant improvement allowances
    		           1,523,000 1,196,000 0 2,042,000 2,232,000 5,663,000 
      issuance of common stock related to the purchase of the ipr&d asset on closing date
    		                 
      contingent consideration payable related to the purchase of the ipr&d asset on closing date
    		                 
      acquisition of pact series d convertible preferred shares
    		                 
      remeasurement of operating lease right-of-use asset for lease modification
    		           2,000 18,000 6,000 5,000   
      gain on marketable equity securities
    		      -1,535,000           
      gain on net operating lease liability disposal
    		                 
      sales and maturities of marketable securities
    		       156,120,000 178,147,000 187,100,000 142,247,000 110,899,000 106,498,000 121,848,000 79,807,000 70,330,000 142,036,000 
      proceeds from initial public offering, net of issuance costs
    		               0 -1,060,000 
      conversion of convertible preferred stock to common stock upon closing of initial public offering
    		               0 0 
      lease expense, net of gain on lease remeasurement
    		                 
      gain on property and equipment disposals
    		                 
      expense in connection with asset acquisition
    		                 
      purchases of other investments
    		                 
      proceeds from issuance of convertible preferred stock, net of issuance costs
    		                 
      payments for the repurchase of common stock
    		                 
      payments for the repurchase of convertible preferred stock
    		                 
      operating lease right-of-use assets obtained in exchange for lease obligations
    		                 
      other investments received for sale of assets
    		                 
      non-cash lease expense
    		                -405,000 
      change in fair value of warrants
    		             14,000 -28,000 57,000 42,000 
      deferred offering costs included in accounts payable and accrued liabilities
    		                 
      depreciation and amortization
    		              4,187,000 4,565,000 4,091,000 
      net amortization or accretion on marketable securities
    		              475,000 467,000 552,000 
      loss on property equipment and disposals
    		              84,000   
      non-cash expense in connection with asset acquisition
    		                 
      loss on remeasurement of convertible preferred stock tranche liabilities
    		                 
      expense in connection with equity issuances
    		                 
      prepaid expenses and other assets
    		               -176,000  
      non-cash deemed dividends on convertible preferred stock
    		                 
      payments for the repurchase of preferred stock
    		                 
      remeasurement of operating lease right of use asset for lease modification
    		                -228,000 
      other
    		                 
      prepaid expense and other assets
    		                 
      accrued liabilities and other liabilities
    		                 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.